论文部分内容阅读
在日本由于大肠癌的发病率较胃癌低,所以与胃癌相比,其早期诊断的普查及诊断技术的提高均落后一步,但自1973年制成“大肠癌规约”以来,随着临床病理学研究的进步和手术术式的改革,使大肠癌的疗效明显提高。本文以产业医科大学第一外科病例为基调,参考有关文献,阐述大肠癌治疗的进展。一、临床资料病例数100例(包括内窥镜息肉切除术),切除91例(切除率94.8%),根治手术73例(根治切除率76%)。姑息切除18例,其原因属S或A因素的5例,H因素的9例,P因素的4例。
In Japan, the incidence of colorectal cancer is lower than that of gastric cancer. Therefore, compared with gastric cancer, the improvement of its early diagnosis and diagnostic techniques is one step behind. However, since the “conformational colorectal cancer” was established in 1973, it has been associated with clinical pathology. Advances in research and surgical reforms have significantly improved the efficacy of colorectal cancer. This article is based on the first surgical case of the University of Industrial Medicine, referring to relevant literature and expounding the progress of colorectal cancer treatment. First, the number of clinical data of 100 cases (including endoscopic polypectomy), removal of 91 cases (resection rate of 94.8%), 73 cases of radical surgery (radical resection rate of 76%). Palliative resection was performed in 18 cases, which was attributed to 5 cases of S or A factors, 9 cases of H factors, and 4 cases of P factors.